NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/17/2025
Back to search
Official data from USPTO
GENOPLEX MICRODELIVERY ACTIVATOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENOPLEX MICRODELIVERY ACTIVATOR
ST13
US500000097350109Class
3
Filing
97350109
Registration
7836418
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
06/17/2025
Trademark type
Word
Nice classes
3
Filing date
04/06/2022
Registration date
06/17/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
06/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/28/2022
First use in commerce
02/28/2022
Drawing code
4
Owner type
03
Owner location
Guelph, CA
Examiner
WOOD, DANIEL PAUL
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Derma Research Group, Inc.
Representatives
Szymon Gurda CHERSKOV FLAYNIK & GURDA, LLC
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Exfoliant creams; Skin rejuvenation creams; Cosmetic microdermabrasion cream
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/17/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/27/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/27/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/19/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/17/2025
EISU
TEAS STATEMENT OF USE RECEIVED
02/27/2025
IUAF
USE AMENDMENT FILED
02/26/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/29/2024
EX2G
SOU EXTENSION 2 GRANTED
08/29/2024
EXT2
SOU EXTENSION 2 FILED
08/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/01/2024
EX1G
SOU EXTENSION 1 GRANTED
02/29/2024
EXT1
SOU EXTENSION 1 FILED
02/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/29/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/29/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/04/2023
PUBO
PUBLISHED FOR OPPOSITION
07/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/14/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/27/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
04/24/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
04/24/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/25/2023
GNRT
NON-FINAL ACTION E-MAILED
01/25/2023
CNRT
NON-FINAL ACTION WRITTEN
01/25/2023
DOCK
ASSIGNED TO EXAMINER
01/23/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/13/2022
NWAP
NEW APPLICATION ENTERED
04/09/2022
Continuous trademark protection
Get notified about every new filing that threatens GENOPLEX MICRODELIVERY ACTIVATOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.